CT ties steroids, early coronary artery disease in Brazilian population

Brazilian researchers used CT angiography to examine atherosclerosis in individuals who have used anabolic androgenic steroids, finding that the drugs could lead to early onset coronary artery disease.

The study, presented Nov. 4 at the Brazilian Congress of Cardiology and led by Francis Ribeiro de Souza, PhD, examined 51 men with an average age of 29—21 who lifted weights and used steroids, 20 who lifted weights but did not use steroids and 10 healthy but sedentary men.

Atherosclerosis was present in the coronary arteries of 24 percent of the steroid users compared to none of the non-users. The steroid users also had lower high-density lipoprotein (HDL) cholesterol levels and reduced HDL function.

“Our study suggests that anabolic androgenic steroid use may be associated with the development of coronary artery disease in apparently healthy young people,” Ribeiro de Souza said. “Steroids may have an impact on the ability of HDL to remove cholesterol from macrophages, thereby promoting atherosclerosis.”

steroid use to atherosclerosis. Larger, longer-term studies are warranted, he said.

“This study despite its small sample size is well done and calls attention to a possible important health problem in Brazil and elsewhere since it shows not only the classical lipid disturbances induced by steroids but actually associates them with subclinical atherosclerosis presence, something that we are not supposed to find in young individuals,” said Raul Santos, MD, PhD, the scientific chair of the conference.

Read more at Cardiovascular Business:

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.